Aurobindo Pharma, a leading pharmaceutical company, has announced the extension of negotiations between its subsidiary, CuraTeQ Biologics, and Merck Sharp […]
This post first appeared on EHEALTH - The Enterprise Of Healthcare, please read the originial post: here
